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Background: To describe the first case of partial vision recovery in a 32-year-old woman with iatrogenic retinal
artery occlusion (RAO) following glabella calcium hydroxylapatite (CaHA) injection, and to explore appropriate
diagnostic and therapeutic measures according to a literature review.
Case presentation: A 32-year-old woman had left eye RAO and a bilateral visual field defect after CaHA injection
into the glabella region. Topical and systemic intraocular pressure lowering agents, isovolemic hemodilution, globe
massage, and anticoagulation with acetylsalicylic acid were prescribed. Carbogen inhalation and oral corticosteroids
were also given. In addition to the above therapies, hyperbaric oxygen therapy (HBOT) was implemented as adjuvant
treatment. The final best corrected visual acuity (BCVA) of the left eye improved from hand motion at 15 cm to 0.1.
Improved retinal circulation and decreased retinal vessel leakage were found in the follow-up fluorescein angiography.
However, there were still multiple emboli in the conjunctival and retinal arteries.
Conclusion: This is the first case report on partial recovery of BCVA after iatrogenic RAO following cosmetic CaHA
injection. Because no reliable treatments have been reported for such complications, HBOT may be considered as an
alternative adjuvant therapy.Background
As soft-tissue augmentation of the face has become more
common, there has been an increasing number of cases of
ocular complications after facial filler injections, including
hypersensitivity reactions, ecchymosis, anterior chamber
inflammation, strabismus, ptosis, ophthalmoplegia, and ret-
inal vessel occlusion [1]. Among these complications, per-
manent visual loss due to retinal artery occlusion (RAO) is
the most devastating. To date, there have been no definite
therapeutic guidelines developed for iatrogenic RAO. Al-
though a few cases with vision improvement were reported
in the past, [2-4] none of these cases were related to RAO
following calcium hydroxylapatite (CaHA, RADIESSE®)
injection. We herein describe a case of iatrogenic RAO
following CaHA filler injection with vision and retinal cir-
culation improvement after treatment. We used hyper-
baric oxygen therapy (HBOT) as adjuvant treatment in
this patient. To the best of our knowledge, this is the first
case report of partial vision recovery in RAO following* Correspondence: jackhyh@gmail.com
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article, unless otherwise stated.CaHA filler injection. We also provide a literature review
to discuss the issues of diagnosis and treatment of this vi-
sion threatening disorder.Case presentation
A 32-year-old woman sought treatment in the emergency
department reporting sudden vision loss in her left eye.
Four hours previously, she received vaginal plastic surgery
and CaHA filler injection into the glabella region by a local
plastic surgeon under general anesthesia. After waking up,
she noted vision loss in her left eye, and was immediately
transferred to our hospital. The initial best-corrected visual
acuity (BCVA) at our emergency department was hand
motion at 15 cm in the left eye and 1.0 in the right. The
left pupil was dilated with a positive relative afferent pa-
pillary defect. There was neither ophthalmoplegia nor
strabismus. Slit lamp examination showed multiple emboli
along the conjunctival vessels (Figure 1). Fundoscopy in
the right eye (OD) revealed normal findings (Figure 2A),
while the left eye (OS) showed multiple emboli in the
whole choroidal layer (Figure 2B). The corresponding
spectral-domain OCT showed normal choroidal vascular-
ity in the right eye (Figure 2C). In the left eye, multiplentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Multiple emboli along the conjunctival vessels.
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tic shadows (arrow head) in the retinal layer, were found
(Figure 2D). Close-up imaging revealed distal RAOs
(Figure 2E). Magnetic resonance imaging (MRI) showed
no evidence of acute brain infarction, however, there were
high-attenuation materials around the glabella region,
which were compatible with the CaHA filler injections
(Figure 3). Fundus fluorescein angiography (FAG) ob-
tained on the second hospital day showed multiple ab-
sences of retinal perfusion in the arteriovenous phaseFigure 2 Fundus picture. (A) Normal in the right eye. (B) There were mu
SD-OCT in the right eye showed normal choroidal vascularity. (D) In the le
the retinal layer, which caused dark acoustic shadows, indicating CaHA em
(arrow) obstructing the distal retinal artery and choroidal layer (circle).(Figure 4A), and fluorescein leaking out of the occlusive ret-
inal artery was found in the late phase (Figure 4B). Under
the diagnosis of iatrogenic RAO, the therapies were admin-
istered to shorten the ischemic period on the basis of the
European Assessment Group for Lysis in the Eye (EAGLE)
guidelines, [5] including topical and systemic intraocular
pressure lowering agents, isovolemic hemodilution, globe
massage, and anticoagulation with acetylsalicylic acid. In
addition, carbogen inhalation and oral corticosteroids were
also provided.
Despite the treatment, progressive blurred vision was
still found in the following few hours. Intra-arterial fibrin-
olysis using recombinant tissue plasminogen activator was
not performed because of higher rates of adverse side ef-
fects [5]. An alternative treatment option, HBOT, was per-
formed. Our patient received 100% oxygen via a face mask
at a maximum ambient pressure of 2.5 atmospheres abso-
lute. The protocol for the treatment was 10 minutes of
compression, followed by a hyperbaric phase of 60 minutes,
and 15 minutes of decompression. The treatment schedule
was HBOT 3 times within the initial 24 hours, and 3 more
treatments within the following 72 hours, for a total of 6
treatments. Conjunctival biopsy (OS) was performed later,
which revealed multiple calcified foreign bodies in the
vessel lumens (Figure 5). The visual acuity remained stable
after the treatments, and the patient was discharged.
Three months after onset, the BCVA improved from handltiple emboli in the whole choroidal layer. (C) The corresponding
ft eye, multiple hyper-reflective depositions (arrow head) were found in
boli. (E) Magnification of the macular region shows multiple emboli
Figure 3 T2W1MRI demonstrated high-attenuation material
around the glabella region (arrow), corresponding with CaHA filler.
Figure 5 The pathology of a conjunctival biopsy showed
several calcified materials (dashed circle) in the capillary lumen.
Normal calcifications are not likely and foreign bodies are more
likely to be present.
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still showed multiple emboli in retinal vessels (Figure 6).
Follow-up fluorescein angiography (FAG) showed im-
proved retinal circulation (Figure 4C) and decreased
retinal vessel leakage (Figure 4D).
Discussion
Our literature review revealed that a retrograde embolic
mechanism is generally thought to be the pathogenesisFigure 4 Fundus fluorescein angiography (FAG) obtained on the seco
arteriovenous phase. (B) Fluorescein leaking out of the occlusive retinal art
revealed recovery of retinal circulation, and (D) decrease retinal vessel leakaof RAO after cosmetic facial filler injections [4,6]. Once an
injection pressure is higher than the systolic arterial pres-
sure, the injected material displaces the arterial blood and
travels proximally past the origin of the retinal artery [7].
When the plunger is released, the arterial systolic pressure
then propels the resulting column of material into the
ophthalmic artery and its branches [6]. We searched
PubMed and MEDLINE (1950 through February 2014)
using the key words “visual loss”, “visual impairment”,
“blindness”, “retinal artery occlusion”, “facial fillers”, “facialnd hospital day. (A) Multiple absences of retinal perfusion in the
ery was found in the late phase. (C) FAG obtained 5 weeks later
ge.
Figure 6 Three months after treatment, the fundoscopic image of
the left eye still showed multiple emboli in retinal vessels (arrow).
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ports of visual disturbance following facial filler injections
were identified through the first screening [2-4,6,8-30].
We excluded the cases of visual disturbance not due to
retinal artery occlusion after cosmetic injections. Only 2
cases met our criteria, which were related to CaHA filler
injection [2,9]. We summarized these 2 cases and made a
comparison with our patient (Table 1).
Our case is the first case report of vision and circulation
improvement in posterior segment ischemia due to CaHA
filler injections. A variety of measures have been advocated
in an attempt to treat non-arteritic retinal artery obstruc-
tion, but there were no generally agreed upon treatment
regimens, with no suggested treatment regimens for iatro-
genic RAO. In 2010, Sung et al. [2] first reported a case
of anterior segment ischemia concurrent with vascular
embolization after injection of CaHA. The main affected
part was the anterior segment, and the involved vessel was
the long posterior ciliary artery. Therapies included a top-
ical antibiotic, topical steroids, and low-dose oral cortico-
steroids. The significant improvement in final visual acuity
was determined by the resolution of corneal edema and
severe anterior chamber inflammation, rather than an im-
provement in the posterior choroidal circulation. Theoret-
ically, a limited nasal choroidal ischemia, sparing the
macula, will not result in an obvious visual acuity disturb-
ance. Kim and Chou reported a patient with bilateral
blindness after CaHA injection in 2013 [9]. The main af-
fected part was the posterior segment, and the involved
vessel was the ophthalmic artery. However, only limited
information on the treatments was provided, and the final
visual outcome was no light perception in both eyes. Inour case, the injured arteries were the retinal artery and
short posterior ciliary artery. We provided the treatment
immediately when the diagnosis was made. We completed
5 steps of a 6-step therapy, which followed the EAGLE
study, [5] including topical and systemic lowering of intra-
ocular pressure agents, ocular massage, hemodilution, and
antiplatelet therapy with acetylsalicylic acid. In addition, in-
terventions that had been used as treatments for acute ret-
inal artery occlusion were provided at the same time,
including carbogen breathing, and low dose oral prednisol-
one. Intra-arterial fibrinolysis using recombinant tissue
plasminogen activator was not performed; instead, HBOT
was implemented in 6 treatments. Three months later, the
BCVA in the left eye increased from HM/15 cm to 0.1, and
the follow-up FAG indicated recovery of retinal perfusion.
In our literature review of 46 case reports, 15 reported
therapies for iatrogenic RAO, including dilation of the ar-
tery by breathing carbon dioxide/carbogen [20] and using
an oral vasodilator, [19,29] physical removal of the obstruc-
tion by ocular massage, [4,20,26,27,29] reduction of intra-
ocular pressure by anterior chamber paracentesis, [4,27]
intravenous acetazolamide or mannitol, [3,4,10,27,29] intra-
arterial thrombolysis, [4,22] anti-platelet therapy, [10,12,19]
reduced red blood cell rigidity by hemodilution, [20] and
systemic steroids to reduce retinal edema [2,11,12,21-24].
Only 4 of the 47 cases, including our case, showed im-
provements in visual acuity [2-4]. The number of cases was
too small to provide a safe, convincing, and reliable treat-
ment protocol for RAO. In our case, we observed a shorter
occlusion time and faster restoration of perfusion. Thus,
the rational goal of treatment should be shortening the oc-
clusion time and increasing perfusion.
The major difference in our case from previous reports
is the early HBOT within 24 hours after the onset of
symptoms. A number of investigations have shown that
early HBOT within 24 hours after the onset of symptoms
had beneficial effects for visual acuity improvements in
eyes with RAO, and there were no serious major compli-
cations [31-34]. However, for iatrogenic RAO, there have
been no case reports or large clinical trials to prove the ef-
ficacy of HBOT. Breathing 100% oxygen under 2.5 atmo-
spheres absolute can increase dissolved plasma oxygen by
almost 17-fold than breathing room air. Under such
hyperbaric conditions, enough dissolved plasma oxygen
can meet the normal requirements of the body at rest
without the need for hemoglobin [35]. Therefore, more
oxygen can be delivered deeper into the ocular tissue, in-
cluding the inner retina via diffusion, to support tissue
survival until recovery of perfusion in patients with iatro-
genic RAO [34]. Thus, though the CaHA particles still
remained in place for a few months after occlusion, we
surmised that the effect of HBOT in iatrogenic RAO could
be the increase in oxygen perfusion into the retina, which
further contributed to the improvement in visual acuity.
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bility of central nervous system infarction. Just as the
injected materials can be pushed into the ophthalmic
artery, an excessive force may also cause retrograde em-
boli into the internal carotid artery, resulting in a cere-
brovascular event. In our review, 7 of the 46 cases (7/46,
15.2%) [4,10,15,17,30,36] had complications with a
stroke event. Of these, 6 cases were following fat transfer,
[4,15,17,30,36] and the remaining case had hyaluronic acid
injection [10]. Therefore, we should pay attention to each
patient’s neurological symptoms and signs. It is recom-
mended that routine neuroimaging examination, such as
CT or MRI, should be arranged in iatrogenic RAO to rule
out the possibility of brain infarction.
Conclusion
In conclusion, considering there are no reported reliable
treatments for iatrogenic RAO, a poor visual acuity out-
come is inevitable. In this report, we offer our experience
with HBOT for the treatment of iatrogenic RAO. We
found that early HBOT had some beneficial effects on ret-
inal perfusion and visual acuity, while there were no major
complications. Therefore, along with recommended treat-
ments by the EAGLE study, [5] HBOT seems worthwhile
for iatrogenic RAO within the initial 24 hours if the equip-
ment and a trained technician are available.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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